UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 8)
DOR BioPharma, Inc.
-------------------
(Name of Issuer)
Common Stock, par value $.001 per share
---------------------------------------
(Title of Class of Securities)
258094101
---------
(CUSIP Number)
Paramount Capital Asset Management, Inc.
----------------------------------------
Lindsay A. Rosenwald, MD
787 Seventh Avenue
New York, NY 10019
(212) 554-4300
(Name, Address and Telephone Number of Person Authorized to Receive Notices
and Communications)
May 22, 2002
------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check
the following box. |_|
Note. Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Section 240.13d-7 for other
parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Continued on following page(s)
Page 1 of 15 Pages
CUSIP NO. 258094101 SCHEDULE 13D Page 2 of 15 Pages
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Lindsay A. Rosenwald, M.D.
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |_|
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO (see Item 3 below)
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(d) or 2(e) |_|
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
2,296,615
--------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 3,466,351
OWNED BY --------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON 2,296,615
WITH --------------------------------------------------------
10 SHARED DISPOSITIVE POWER
3,466,351
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
55,762,966
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* |_|
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
24.8%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------------
CUSIP NO. 258094101 SCHEDULE 13D Page 3 of 15 Pages
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Paramount Capital Asset Management, Inc.
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |_|
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO (see Item 3 below)
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(d) or 2(e) |_|
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
None
--------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 3,466,351
OWNED BY --------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON None
WITH --------------------------------------------------------
10 SHARED DISPOSITIVE POWER
3,466,351
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,466,351
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* |_|
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
15.9%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
CO
--------------------------------------------------------------------------------
CUSIP NO. 258094101 SCHEDULE 13D Page 4 of 15 Pages
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Aries Select, Ltd.
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |_|
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO (see Item 3 below)
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(d) or 2(e) |_|
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
None
--------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 2,369,986
OWNED BY --------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON None
WITH --------------------------------------------------------
10 SHARED DISPOSITIVE POWER
2,369,986
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,369,986
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* |_|
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
10.9%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
OO
--------------------------------------------------------------------------------
CUSIP NO. 258094101 SCHEDULE 13D Page 5 of 15 Pages
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Aries Select Domestic I, LLC
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |_|
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO (see Item 3 below)
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(d) or 2(e) |_|
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
None
--------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 1,076,081
OWNED BY --------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON None
WITH --------------------------------------------------------
10 SHARED DISPOSITIVE POWER
1,076,081
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,076,081
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* |_|
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
5.0%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
OO
--------------------------------------------------------------------------------
CUSIP NO. 258094101 SCHEDULE 13D Page 6 of 15 Pages
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Aries Select Domestic II, LLC
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) |_|
(b) |_|
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO (see Item 3 below)
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(d) or 2(e) |_|
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
None
--------------------------------------------------------
NUMBER OF 8 SHARED VOTING POWER
SHARES
BENEFICIALLY 20,284
OWNED BY --------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
REPORTING
PERSON None
WITH --------------------------------------------------------
10 SHARED DISPOSITIVE POWER
20,284
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
20,284
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES* |_|
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.1%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
OO
--------------------------------------------------------------------------------
Page 7 of 15 Pages
Item 1. Item 1. Security and Issuer.
(a) Common Stock, $.001 par value ("Shares")
Dor BioPharma, Inc. (the "Issuer")
28101 Ballard Drive, Suite F
Lake Forrest, IL 60045
(847) 573-8990
Item 2. Identity and Background.
Names of Persons Filing:
(a) This statement is filed on behalf of Paramount Capital Asset
Management, Inc. ("Paramount Capital"), Aries Select, Ltd., a Cayman
Island exempted company ("Aries Select"), Aries Select I LLC ("Aries
I"), Aries Select II LLC ("Aries II") and Lindsay A. Rosenwald, M.D.
("Dr. Rosenwald" and collectively, "Reporting Parties").
(b) Paramount Capital's, Aries I's, Aries II's and Dr. Rosenwald's
business address is 787 Seventh Avenue, 48th Floor, New York, New
York, 10019. The business address for Aries Select is c/o Fortis
Fund Services (Cayman) Limited, P.O. Box 2003, British American
Centre, Phase 3, Dr. Roy's Drive, George Town, Grand Cayman.
(c) Dr. Rosenwald is an investment banker, venture capitalist, fund
manager and sole shareholder of Paramount Capital, a Subchapter S
corporation incorporated in Delaware. Paramount Capital is the
managing member of Aries I and Aries II, each a limited liability
corporation incorporated in Delaware. Paramount Capital is the
Investment Manager to Aries Select, a Cayman Islands exempted
company. The principal business of Aries I, Aries II and Aries
Select is investment in securities.
(d) Dr. Rosenwald, Paramount Capital, Aries I, Aries II and Aries Select
and their respective officers, directors, general partners,
investment managers, or trustees have not, during the five years
prior to the date hereof, been convicted in a criminal proceeding
(excluding traffic violations or similar misdemeanors).
(e) Dr. Rosenwald, Paramount Capital, Aries I, Aries II and Aries Select
and their respective officers, directors, general partners,
investment managers, or trustees have not been, during the five
years prior to the date hereof, parties to a civil proceeding of a
judicial or administrative body of competent jurisdiction, as a
result of which such person was or is subject to a judgment, decree
or final order enjoining future violations of, or prohibiting or
mandating activities subject to, Federal or State securities laws or
finding any violation with respect to such laws.
(f) Dr. Rosenwald is a citizen of the United States.
Page 8 of 15 Pages
Item 3. Source and Amount of Funds or Other Consideration.
Since the date of Amendment No. 7 ("Amendment No. 7") filed on
December 30, 1999, the Issuer merged (the "Merger") with Corporate
Technology Developments (`CTD"). Pursuant to the terms of the
Merger, Dr. Rosenwald and certain entities controlled by Dr.
Rosenwald received Shares.
Item 4. Purpose of Transaction.
The Reporting Parties acquired Shares as an investment in the
Issuer.
Although the Reporting Parties have not formulated any definitive
plans, they may from time to time acquire, or dispose of, Shares
and/or other securities of the Issuer if and when they deem it
appropriate. The Reporting Parties may formulate other purposes,
plans or proposals relating to any of such securities of the Issuer
to the extent deemed advisable in light of market conditions,
investment policies and other factors.
The Schedule 14A filed by the Issuer on April 30, 2002, included,
among other things, a proposal for reelection of the nine incumbent
directors of the Issuer at the Annual Meeting of Stockholders to be
held on May 23, 2002 (the "Annual Meeting").
On May 22, 2002, Dr. Rosenwald received a proxy request from Steven
H. Kanzer ("Mr. Kanzer"), who, in his capacity as a shareholder,
solicited Dr. Rosenwald's proxy at the Annual Meeting. Specifically,
Mr. Kanzer requested that Dr. Rosenwald support an alternate slate
of nine (9) directors which includes three (3) individuals that are
not incumbent directors. After due consideration, Dr. Rosenwald has
decided to execute the revocable proxy proffered by Mr. Kanzer.
Except as indicated in this Schedule 13D, the Reporting Parties
currently have no plans or proposals that relate to or would result
in any of the matters described in subparagraphs (a) through (j) of
Item 4 of Schedule 13D.
Item 5. Interest in Securities of the Issuer.
(a) As of May 22, 2002, Dr. Rosenwald beneficially owned 5,762,966
Shares or 24.8% of the total amount of Shares outstanding
assuming the exercise of all of the securities held by the
following:
Percent Amount Owned
------- ------------
Aries Select 10.9% 2,214,493 Shares
155,493 warrants to purchase Shares
Aries I 5.0% 996,215 Shares and
79,866 warrants to purchase Shares
Aries II 0.1% 20,284 Shares
Page 9 of 15 Pages
PCDDH(2) 2.4% 591,673 Shares
June Street(2) 0.1% 12,560 Shares
Huntington Street(2) 0.1% 12,560 Shares
Dr. Rosenwald 24.8%(1) 163,320 Shares and 1,516,502 warrants
to purchase Shares
(b) Dr. Rosenwald and Paramount Capital share the power to vote or
to direct the vote, to dispose or to direct the disposition of
those shares owned by each of Aries Select, Aries I and Aries
II.
(c) Other than the receipt of Shares released from escrow pursuant
to the terms of the Merger, on or about April 3, 2002, which
include 13,163 Shares received by Dr. Rosenwald directly,
1,102 Shares received by each of Huntington Street and June
Street, and 131,277 Shares received by PCDDH and as otherwise
set forth herein the Reporting Parties have not engaged in any
transactions in Shares during the past 60 days.
(d) Not applicable
(e) Not applicable.
-------------------
1. For purposes of this Regulation 13-D filing, Dr. Rosenwald's percentage
calculation includes all of the securities owned by Paramount Capital,
Aries I, Aries II, Aries Select, PCDDH, June Street and Huntington Street.
Dr. Rosenwald disclaims beneficial ownership of any securities, including
the Shares, not held directly for his account.
2 Dr. Rosenwald is also sole and managing member of Paramount Capital Drug
Development Holdings, LLC ("PCDDH") and sole proprietor of each of
Huntington Street Company ("Huntington Street") and June Street Company
("June Street").
Page 10 of 15 Pages
Item 6. Contracts, Arrangements, Understandings or Relationships with respect to
Securities of the Issuer:
Item 4 is herein incorporated by reference.
Paramount Capital is the Investment Manager of Aries Select and the
Managing Member of each of Aries I and Aries II and in such
capacities has the authority to make certain investment decisions on
behalf of such entities, including decisions relating to the
securities of the Issuer. In connection with its investment
management duties, Paramount Capital receives certain management
fees and performance allocations from the Aries Select, Aries I and
Aries II.
Pursuant to the terms of the Merger certain Shares are currently
being held in escrow and will be released upon the occurrence of
certain events. Upon achievement of such milestones, the Issuer will
issue additional Shares as follows:
PCDDH: 91,101 Shares
June Street: 1,012 Shares
Hunting Street: 1,012 Shares
Dr. Rosenwald: 13,163 Shares
Mr. Steve Kanzer joined the Board of Directors of the Issuer in
connection with the initial investment by the predecessors in
interest to Aries Select, Aries I and Aries II.
Dr. Rosenwald is also the Chairman and sole stockholder of Paramount
Capital, Inc. ("PCI"), an NASD member broker dealer. PCI has acted
as placement agent for the Issuer and has received certain fees for
such services including warrants to purchase Shares.
Item 7. Material to be Filed as Exhibits:
Exhibit A - Copy of an Agreement between Dr. Rosenwald, Paramount Capital,
Aries Select and Aries I to file this Statement on Schedule 13D
on behalf of each of them.
Exhibit B - List of executive officers and directors of Paramount Capital and
information called for by Items 2-6 of this statement relating to
said officers and directors.
Exhibit C - List of executive officers and directors of Aries Select and
Aries II and information called for by Items 2-6 of this
statement relating to said officers and directors.
Exhibit D - List of executive officers and directors of Aries I and
information called for by Items 2-6 of this statement relating to
said officers and directors.
Page 11 of 15 Pages
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true, complete and
correct.
PARAMOUNT CAPITAL ASSET MANAGEMENT, INC.
Dated: May 23, 2002
New York, NY By /s/ Lindsay A. Rosenwald, M.D.
------------------------------------------------
Lindsay A. Rosenwald, M.D.
Chairman
ARIES SELECT DOMESTIC I, LLC
By: Paramount Capital Asset Management, Inc.
Managing Member
Dated: May 23, 2002
New York, NY By /s/ Lindsay A. Rosenwald, M.D.
------------------------------------------------
Lindsay A. Rosenwald, M.D.
Chairman
ARIES SELECT DOMESTIC II, LLC
By: Paramount Capital Asset Management, Inc.
General Partner
Dated: May 23, 2002
New York, NY By /s/ Lindsay A. Rosenwald, M.D.
------------------------------------------------
Lindsay A. Rosenwald, M.D.
Chairman
ARIES SELECT, LTD.
By: Paramount Capital Asset Management, Inc.
Investment Manager
Dated: May 23, 2002
New York, NY By /s/ Lindsay A. Rosenwald, M.D.
------------------------------------------------
Lindsay A. Rosenwald, M.D.
Chairman
Dated: May 23, 2002
New York, NY By /s/ Lindsay A. Rosenwald, M.D.
------------------------------------------------
Lindsay A. Rosenwald, M.D.
Page 12 of 15 Pages
AGREEMENT
JOINT FILING OF SCHEDULE 13D
The undersigned hereby agrees to jointly prepare and file with
regulatory authorities a Schedule 13D and any future amendments thereto
reporting each of the undersigned's ownership of securities of DOR BioPharma,
Inc. and hereby affirm that such Schedule 13D is being filed on behalf of each
of the undersigned.
PARAMOUNT CAPITAL ASSET MANAGEMENT, INC.
Dated: May 23, 2002
New York, NY By /s/ Lindsay A. Rosenwald, M.D.
------------------------------------------------
Lindsay A. Rosenwald, M.D.
Chairman
ARIES SELECT DOMESTIC I, LLC
By: Paramount Capital Asset Management, Inc.
Managing Member
Dated: May 23, 2002
New York, NY By /s/ Lindsay A. Rosenwald, M.D.
------------------------------------------------
Lindsay A. Rosenwald, M.D.
Chairman
ARIES SELECT DOMESTIC II, LLC
By: Paramount Capital Asset Management, Inc.
General Partner
Dated: May 23, 2002
New York, NY By /s/ Lindsay A. Rosenwald, M.D.
------------------------------------------------
Lindsay A. Rosenwald, M.D.
Chairman
ARIES SELECT, LTD.
By: Paramount Capital Asset Management, Inc.
Investment Manager
Dated: May 23, 2002
New York, NY By /s/ Lindsay A. Rosenwald, M.D.
------------------------------------------------
Lindsay A. Rosenwald, M.D.
Chairman
Dated: May 23, 2002
New York, NY By /s/ Lindsay A. Rosenwald, M.D.
------------------------------------------------
Lindsay A. Rosenwald, M.D.
Page 13 of 15 Pages
EXHIBIT B
The name and principal occupation or employment, which in each instance is
with Paramount Capital Asset Management, Inc. ("Paramount Capital") located at
787 Seventh Avenue, 48th Floor, New York, New York, 10019, of each executive
officer and director of Paramount Capital is as follows:
PRINCIPAL OCCUPATION
NAME OR EMPLOYMENT
---- -------------
Lindsay A. Rosenwald, M.D. Chairman of the Board of Paramount Capital Asset
Management, Inc., Paramount Capital Investments,
LLC and Paramount Capital, Inc.
Mark C. Rogers, M.D. President of Paramount Capital Asset Management,
Inc., Paramount Capital Investments, LLC and
Paramount Capital, Inc.
Peter Morgan Kash Director of Paramount Capital Asset Management,
Inc., Senior Managing Director, Paramount
Capital, Inc.
Dr. Yuichi Iwaki Director of Paramount Capital Asset Management,
Inc., Professor, University of Southern
California School of Medicine
Item 2.
During the five years prior to the date hereof, none of the above persons
(to the best of Paramount Capital's knowledge) was convicted in a criminal
proceeding (excluding traffic violations or similar misdemeanors) or was a party
to a civil proceeding of a judicial or administrative body of competent
jurisdiction, as a result of which such person was or is subject to a judgment,
decree or final order enjoining future violations of, or prohibiting or
mandating activities subject to, Federal or State securities laws or finding any
violation with respect to such laws.
Items 3-6.
Please refer to Items 3-6 herein reporting the beneficial ownership.
Page 14 of 15 Pages
EXHIBIT C
The name and principal occupation or employment, which is located at
787 Seventh Avenue, 48th Floor, New York, New York, 10019, of the Managing
Member of Aries I and Aries II is as follows:
PRINCIPAL OCCUPATION
NAME OR EMPLOYMENT
---- -------------
Paramount Capital Asset Management, Inc. Investment Manager
Exhibit B is hereby incorporated by reference.
Item 2.
During the five years prior to the date hereof, the above person (to the
best of Aries Domestic's knowledge) has not been convicted in a criminal
proceeding (excluding traffic violations or similar misdemeanors) or was a party
to a civil proceeding of a judicial or administrative body of competent
jurisdiction, as a result of which such person was or is subject to a judgment,
decree or final order enjoining future violations of, or prohibiting or
mandating activities subject to, Federal or State securities laws or finding any
violation with respect to such laws.
Items 3-6.
Please refer to Items 3-6 herein reporting the beneficial ownership.
Page 15 of 15 Pages
EXHIBIT D
The name and principal occupation or employment, which in each instance is
with Aries Select, Ltd. ("Aries Select") located at c/o Fortis Fund Services
(Cayman), P.O. Box 2003, British American Centre, Phase 3, Dr. Roy's Drive,
George Town, Grand Cayman, of each executive officer and director of Aries Trust
is as follows:
PRINCIPAL OCCUPATION
NAME OR EMPLOYMENT
---- -------------
Paramount Capital Asset Management, Inc. Investment Manager
Fortis Fund Services (Cayman) Administrator
Exhibit B is hereby incorporated by reference.
Item 2.
During the five years prior to the date hereof, neither of the above
persons (to the best of Aries Select's knowledge) have been convicted in a
criminal proceeding (excluding traffic violations or similar misdemeanors) or
was a party to a civil proceeding of a judicial or administrative body of
competent jurisdiction, as a result of which such person was or is subject to a
judgment, decree or final order enjoining future violations of, or prohibiting
or mandating activities subject to, Federal or State securities laws or finding
any violation with respect to such laws.
Items 3-6.
Please refer to Items 3-6 herein reporting the beneficial ownership.